Ocular and periocular malignancies: incorporating radiotherapy in multimodality treatment

1st March 2022  09:00 - 16:30 (GMT+00:00) GMT

BIR virtual event - Tuesday 1 March 2022
09:00 - 16:30 GMT
CPD: 6 credits

The objective of this new virtual event hopes to share expertise and best practice in invasive and non invasive management of ocular and periocular tumours with emphasis on malignant disease. The main focus will be on surgery and radiotherapy but the event will also provide perspectives from other healthcare professionals involved in the management of ocular and periocular tumours.

View programme here

Who will benefit from this event

  • Radiotherapy: Consultant/Registrar Clinical Oncologists/Radiation Oncologists/Therapeutic Radiographers/Medical Physicists/Dosimetrists
  • Oculoplastic surgery, Plastic surgery, Oral and Maxillofacial surgery: Consultant/Registrar
  • Other clinical specialties – healthcare professionals involved in the management of ocular tumours (e.g. ophthalmologists, radiologists, optometrists, orthoptists, nurses etc.)


EARLY BIRD Registration fees:

Non members £135
Plan 1 members £90
Plan 2/Trainee members £80
Retired/student member £55
*EARLY BIRD rates expire on Tuesday 1 February 2022

Registration fees:


Non-members £140

World Partner Network members £95

BIR Plan 1 members £95

BIR Plan 2 members £85

BIR International members £85

BIR Trainee members £85

BIR Retired / Student members £65

Registration instructions
In order to register for this event you must first create a MyBIR portal or login to your MyBIR account via this link and then register for the event after you have logged in. The MyBIR portal is a free account with the BIR which will allow you to register for events and to retrieve receipts and CPD certificates. Once this is created, you can then register onto the event. If you have registered for a BIR event in the past you can login to your account first and then click on the register now button. You do not need to be a member of BIR or a radiologist to register for this event. All healthcare professionals are welcome. If you are having any issues registering please email conference@bir.org.uk

Please ensure that you have read the events terms and conditions here, before booking onto an event.




Advanced Accelerator Applications

Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA currently has over 1,000 employees working across 31 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries, and six research & development sites. For more information, please visit: https://www.adacap.com/.

Bayer Healthcare

Bayer’s Radiology business is well placed to be the partner of choice in helping NHS trusts to address the many challenges faced today including the increasing need for governance to demonstrate best practice and improving patient care within increasing financial constraints. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management. 0118 2063999 www.radiology.bayer.co.uk

GE Healthcare Ltd

GE Healthcare is a leading provider of medical imaging, monitoring, and life science technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services to help providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.

Philips Healthcare

Enabling better health and better care at lower cost Philips is a leading health technology company focused on improving people`s lives across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips delivers integrated solutions that improve people`s health and enable better outcomes. Partnering with its customers, Philips seeks to transform how healthcare is delivered and experienced. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. www.philips.co.uk/healthcare

Siemens Healthineers

Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. Further information is available at www.siemens-healthineers.co.uk.